Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 21, 2017
MilliporeSigma has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, for its use in gene therapies.
read more
Thursday, December 21, 2017
JSR Corporation has agreed to purchase Crown Bioscience International at 12 Billion New Taiwan Dollar.
read more
Thursday, December 21, 2017
Impax Laboratories has entered into a definitive agreement to sell its manufacturing facility in Taiwan to Bora Pharmaceuticals.
read more
Friday, December 22, 2017
MedPharm has received positive outcomes from recent cGMP and GLP inspections in 2017.
read more
Friday, December 22, 2017
SSCI has increased capacity in response to industry demand for the company’s cGMP particle characterization services by implementing Malvern’s next-generation laser diffraction instrument Mastersizer 3000.
read more
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Wednesday, December 27, 2017
MilliporeSigma announced a collaboration with IPS-Integrated Project Services and G-CON to provide 2,000L MAb facility and single-use process technology platform.
read more
Wednesday, December 27, 2017
TxCell has completed the development of its first-generation production process for its proprietary CAR-Treg technology.
read more
Friday, December 29, 2017
HTG Molecular Diagnostics announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany.
read more
Shire has filed its first submission to the United States Food and Drug Administration for the company’s new plasma manufacturing facility in Covington, Georgia.
read more
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more
Thursday, January 04, 2018
Beacon Discovery has entered into a collaboration agreement with Janssen Pharmaceuticals.
read more
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
Sharp has completed the first phase in the development of its new USD $23m facility in Bethlehem, PA.
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more